Format

Send to

Choose Destination
Stem Cell Res. 2019 Nov 2;41:101646. doi: 10.1016/j.scr.2019.101646. [Epub ahead of print]

Generation of an induced pluripotent stem cell line (SYSUi002-A) from a patient with coronary slow flow phenomenon.

Author information

1
Cardiovascular Department, The Eighth Affiliated Hospital, Sun Yat-sen University, Shennan Middle Road 3025#, Shenzhen 518033, China; Center for Stem Cell Biology and Tissue Engineering, Key Laboratory for Stem Cells and Tissue Engineering, Ministry of Education, Zhongshan School of Medicine, Sun Yat-Sen University, Guangzhou, Guangdong, China; Guangzhou Regenerative Medicine and Health Guangdong Laboratory, Guangzhou, China.
2
VIP Medical Service Center, The Third Affiliated Hospital of Sun Yat-sen University, No. 600 Tianhe Road, Tianhe District, Guangzhou, China.
3
VIP Medical Service Center, The Third Affiliated Hospital of Sun Yat-sen University, No. 600 Tianhe Road, Tianhe District, Guangzhou, China. Electronic address: 377165615@qq.com.
4
Cardiovascular Department, The Eighth Affiliated Hospital, Sun Yat-sen University, Shennan Middle Road 3025#, Shenzhen 518033, China. Electronic address: wuguifu@mail.sysu.edu.cn.

Abstract

The coronary slow flow phenomenon (CSFP) is characterized by delayed progression of the injected contrast medium through the coronary tree during coronary angiography due to unknown mechanisms. Here, a human induced pluripotent stem cell (iPSC) line (SYSUi002-A) was established using the Sendai-virus delivery system from dermal fibroblasts of a CSFP patient. This cell line may represent a valuable tool for investigating the pathogenesis and therapeutic strategies of CSFP.

PMID:
31783296
DOI:
10.1016/j.scr.2019.101646
Free full text

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center